drugset / Trial / NCT00002691
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and using drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating pediatric patients with stage III or stage IV non-Hodgkin's lymphoma.
Timeline
- Start
- 1995-08
- Primary completion
- 2000-06
- Completion
- 2000-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Daunorubicin | Small molecule | — | — |
| Subject | Dexamethasone | Small molecule | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Vincristine | Small molecule | — | — |
| Subject | asparaginase | Protein / enzyme biologic | — | — |
| Background | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | — | — |
| Background | Leucovorin | Small molecule | — | — |
| Background | filgrastim | Protein / enzyme biologic | — | — |